AI-Native Biotech and the Digital Transformation of China's Bio-Economy
The "Lab Bench" is being replaced by the "Supercomputer" as the heart of pharmaceutical R&D this year. In 2026, the China Biopharmaceuticals Market is being defined by the rise of "AI-Native" biotechs—companies that were built from the ground up to use artificial intelligence for every step of the drug discovery process. These firms have moved beyond simple "Deep Learning" to use...
0 ความคิดเห็น 0 แชร์ 139 ยอดวิว 0 รีวิว